Purdue Pharma Paid to Hack Your Doctor’s Prescription Software

On April 28, 2026, Purdue Pharma was sentenced to pay over $5 billion in criminal penalties for its role in fueling the opioid epidemic through illegal kickback schemes and deceptive marketing.

The company pleaded guilty to conspiracy charges in 2020, including paying nearly $1 million to an electronic health records company to prompt doctors to prescribe more OxyContin. Vermont prosecutors helped uncover the scheme that contributed to a crisis that has destroyed families nationwide.

If you’ve ever wondered how OxyContin became the go-to prescription for everything from wisdom tooth removal to chronic back pain, here’s your answer: Purdue Pharma was literally paying to hack your doctor’s computer.

Purdue Pharma finally faced the music when a federal court ordered the company to pay $5.544 billion in fines and forfeiture for deliberately engineering the opioid epidemic. This wasn’t an accident or oversight but instead a calculated business strategy that prioritized profits over the lives of patients who trusted their doctors.

The sentencing caps a case that began over 6 years ago when Vermont prosecutors discovered Purdue was paying kickbacks to manipulate prescription software. Between April and December 2016, the company paid nearly $1 million to Practice Fusion, an electronic health records company, to install prompts that would push doctors to prescribe more OxyContin, Butrans, and Hysingla.

How the kickback scheme actually worked

The mechanism was simple and devastating. Purdue knew that doctors relied on electronic health record systems to make prescribing decisions. So they paid Practice Fusion to embed prompts in the software that would “remind” doctors to consider Purdue’s extended-release opioids for patients.

The software prompts appeared legitimate — like clinical decision support tools designed to help doctors. But they were actually paid advertisements disguised as medical guidance.

Robert S. Miller, Chairman of Purdue’s Board of Directors, admitted in federal court that the company knew this was illegal. They knew the Anti-Kickback Statute prohibited paying for prescription referrals. They did it anyway because it worked.

Doctors had no idea they were being manipulated by Purdue’s marketing department every time they opened a patient file. When your physician pulled up your chart and saw a suggestion to consider OxyContin for your pain, they thought it was medical software helping them make better decisions.

It was actually Purdue whispering in their ear.

The $5 billion breakdown (and what it actually means)

The court ordered Purdue to pay:

• $3.544 billion criminal fine — assessed through bankruptcy proceedings
• $2 billion criminal forfeiture — with up to $1.775 billion credited if the company becomes a public benefit entity

Here’s the catch: Purdue is in bankruptcy. The $3.544 billion fine gets added to the pile of claims that bankruptcy creditors are fighting over. The $2 billion forfeiture can be reduced by nearly $1.8 billion if Purdue emerges from bankruptcy as a “public benefit company” designed to help with opioid treatment.

Translation: The actual cash Purdue pays will likely be much less than $5 billion. But the proceeds from any public benefit company would go directly to state and local opioid treatment programs — which means the money would actually reach communities instead of disappearing into legal fees.

What Vermont prosecutors found (that everyone else missed)

True to form, it took prosecutors from Vermont — not the FDA, not the DEA, not any of the federal agencies supposedly watching pharmaceutical companies — to uncover how deep this manipulation went.

The Vermont investigation revealed something crucial that other enforcement actions had missed: Purdue wasn’t just marketing aggressively to doctors. They were paying technology companies to manipulate the tools doctors used to make medical decisions.

Former Assistant U.S. Attorneys Owen Foster and Michael Drescher and health care fraud investigator George Thabault uncovered evidence that Purdue was essentially buying prescription recommendations through software manipulation.

This was the first time in history that a pharmaceutical company was found guilty of conspiring with an electronic health records company.

The scheme worked because doctors trusted their electronic systems. When a prompt appeared suggesting an opioid prescription, it looked like clinical guidance — not a paid advertisement from Purdue’s marketing team.

The pattern that keeps repeating (and why it’s hard to stop)

Purdue’s strategy reveals why pharmaceutical accountability is so difficult to achieve. The company didn’t just lie to patients — they corrupted the information systems that doctors rely on to make treatment decisions. When the prescription software itself becomes a marketing tool, patients have no way to know they’re being targeted.

The incentive structure is straightforward: Purdue made billions from OxyContin sales. Even a $5 billion penalty is manageable when spread across decades of profits. The company calculated that the marketing benefits outweighed the legal risks — and they were probably right.

Acting Attorney General Todd Blanche acknowledged this in his statement:

“Purdue Pharma put profits over patient health and safety. The company willfully rejected the law and ignored the diversion of their highly addictive prescription drugs.”

Predictably, this won’t be the last pharmaceutical company caught manipulating prescription decisions. The business model is too profitable, and the penalties — even $5 billion ones — are still just the cost of doing business.

What You Can Do

Check if you’re eligible for opioid settlement funds:

1. Visit your state attorney general’s website (find yours at naag.org) and search for “opioid settlement” — many states have established victim compensation programs
2. If you were prescribed OxyContin, Butrans, or Hysingla and developed addiction, document your medical records and prescription history
3. Contact a qualified attorney who handles opioid litigation — many work on contingency and can help determine if you qualify for existing or future settlements

Track the bankruptcy proceedings:

• Monitor Purdue’s bankruptcy case through the court’s electronic filing system — case details and settlement distributions are public record
• If Purdue becomes a public benefit company, watch for announcements about how proceeds will be distributed to affected communities

This Wasn’t Marketing. It Was System-Level Manipulation.

Purdue Pharma didn’t just push opioids — it rewired the system doctors trusted to make medical decisions. By embedding paid prompts into prescription software, the company blurred the line between clinical guidance and advertising, turning patient care into a sales funnel.

Even now, the $5 billion headline number masks a more complicated reality. Bankruptcy proceedings, credits, and restructuring mean the actual financial impact may be far less than it appears — raising the same question we’ve seen across mass torts: When does a penalty become just another line item?

Report ongoing prescription manipulation:

• If your doctor’s electronic health records system seems to push specific brand-name drugs, report it to your state medical board
• Ask your doctor if they receive any payments from pharmaceutical companies — this information is public at cms.gov/openpayments

Companies Behaving Badly will keep pressing the issue. If a company can secretly influence what your doctor prescribes, what else is happening behind the screen?

If Purdue Pharma prescribed you addictive opioids through deceptive marketing, tell us what happened.

Written by: Companies Behaving Badly

The team behind it all.